Home › Funds › Capricorn Fund Managers Ltd › CYTK

Capricorn Fund Managers Ltd position in CYTK

CYTOKINETICS INC · Health Care

Capricorn Fund Managers Ltd reported holding 240,200 shares of CYTK (CYTOKINETICS INC) in its Q3 2026 13F filing — a position valued at US$15.8M, representing 1.52% of its reported portfolio and ranking #19 among its reported holdings. Capricorn Fund Managers Ltd has disclosed CYTK holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)240.20K sh
Reported value held$15.83M
Portfolio Weight1.52%
First reportedQ2 2026
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Capricorn Fund Managers Ltd's CYTK position evolved

Capricorn Fund Managers Ltd first disclosed a stake in CYTK in Q2 2026 at 81,879 shares (US$7.0M). The position peaked in Q3 2026 at 240,200 shares, worth US$15.8M. Across 2 filings, Capricorn Fund Managers Ltd increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 240,200 shares valued at US$15.8M — an increase of 158,321 shares quarter over quarter.. Notable position changes include a 193% increase in Q3 2026 (shares fell 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 81.88K $6.98M New
Q3 2026 240.20K $15.83M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CYTK and 13F data

CYTK (CYTOKINETICS INC) is a Health Care company. 44 other funds we track also report a position in CYTK — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.59B), Avoro Capital Advisors LLC (US$425.9M), RTW INVESTMENTS, LP (US$243.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CYTK

All CYTK fund holders →

FAQ

How long has Capricorn Fund Managers Ltd held CYTK?

Capricorn Fund Managers Ltd has disclosed CYTK holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Capricorn Fund Managers Ltd's current position in CYTK?

As of Q3 2026, Capricorn Fund Managers Ltd holds 240.20K shares of CYTK (CYTOKINETICS INC), valued at $15.83M, representing 1.52% of its reported portfolio and ranking #19.

Has Capricorn Fund Managers Ltd been buying or selling CYTK?

In the latest 13F filing (Q3 2026), Capricorn Fund Managers Ltd increased its position in CYTK. The position peaked in Q3 2026 at 240.20K shares.

Which other funds hold CYTK?

Other major institutional holders of CYTK include T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.